Grants per year
Personal profile
Research Interests
The goal of Dr. Penaloza's research is to understand the basic mechanisms of immune regulation and to use this information to develop vaccines and regimens against chronic infections, such as HIV and HCV, as well as cancers.
Training Experience
| 2014 | Postdoctoral Fellowship, Beth Israel Deaconess Medical Center |
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Emory University
… → 2011
Research interests
- AIDS
- HIV Infection
- Immune Regulation
- Infectious Diseases
- Microbiology
- Vaccine Science
- Virology
Fingerprint
Dive into the research topics where Pablo Penaloza-MacMaster is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Diversity Supplement for Sarah Sanchez, Interferon-modulated vaccines against HIV
Penaloza-MacMaster, P. & Miller, S. D.
National Institute on Drug Abuse
7/1/20 → 6/30/24
Project: Research project
-
Interferon-modulated vaccines against HIV
National Institute on Drug Abuse
7/1/20 → 6/30/24
Project: Research project
-
T regulatory cell responses during viral infection
National Institute of Allergy and Infectious Diseases
6/8/18 → 5/31/20
Project: Research project
-
Development of Immune-Modulated HIV Vaccines
National Institute of Allergy and Infectious Diseases
8/15/16 → 7/31/18
Project: Research project
-
Subproject for Institution # SP0033269 Institutional Research Grant for Dr. Pablo Penaloza-MacMaster
1/1/16 → 12/31/18
Project: Research project
-
Nanotraps for the containment and clearance of SARS-CoV-2
Chen, M., Rosenberg, J., Cai, X., Hsuan Lee, A. C., Shi, J., Nguyen, M., Wignakumar, T., Mirle, V., Edobor, A. J., Fung, J., Donington, J. S., Shanmugarajah, K., Lin, Y., Chang, E., Randall, G., Penaloza-MacMaster, P., Tian, B., Madariaga, M. L. & Huang, J., Jun 2 2021, In: Matter. 4, 6, p. 2059-2082 24 p.Research output: Contribution to journal › Article › peer-review
-
Early type I IFN blockade improves the efficacy of viral vaccines
Palacio, N., Dangi, T., Chung, Y. R., Wang, Y., Loredo-Varela, J. L., Zhang, Z. & Penaloza-MacMaster, P., Dec 7 2020, In: Journal of Experimental Medicine. 217, 12, 20191220.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Interrogating Adaptive Immunity Using LCMV
Dangi, T., Chung, Y. R., Palacio, N. & Penaloza-MacMaster, P., Sep 1 2020, In: Current Protocols in Immunology. 130, 1, e99.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
Wang, Y., Chung, Y. R., Eitzinger, S., Palacio, N., Gregory, S., Bhattacharyya, M. & Penaloza-MacMaster, P., Feb 2019, In: PLoS pathogens. 15, 2, e1007583.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Adenovirus vector vaccination impacts NK cell Rrheostat function following lymphocytic choriomeningitis virus infection
Blass, E., Aid, M., Martinot, A. J., Larocca, R. A., Kang, Z. H., Badamchi-Zadeh, A., Penaloza-MacMaster, P., Reeves, R. K. & Barouch, D. H., Jun 1 2018, In: Journal of virology. 92, 11, e02103-17.Research output: Contribution to journal › Article › peer-review
3 Scopus citations